Endocrine Disruption Testing: Technical Overview, Methods, Standards, and Applications

Endocrine disruption testing identifies and quantifies endocrine-disrupting chemicals (EDCs)—such as bisphenol A, phthalates, alkylphenols, parabens, and organotins—in consumer products, food contact materials, textiles, and environmental samples. By combining targeted chromatographic analysis with OECD-validated in vitro and in vivo bioassays, accredited third-party laboratories help manufacturers demonstrate compliance with REACH, RoHS, CPSIA, EN, ISO, and GB requirements. This technical guide explains the scope of EDC testing, sample types, target analytes, analytical methods, and typical applications.

Technical Overview

Endocrine disruption testing evaluates materials, products, and environmental samples for substances that can interfere with the hormonal system. According to the widely cited WHO/IPCS definition, an endocrine disruptor is an exogenous substance or mixture that alters the function of the endocrine system and consequently causes adverse health effects in an intact organism, its progeny, or populations. Endocrine-disrupting chemicals (EDCs) act through multiple mechanisms, including binding to estrogen (ER), androgen (AR), and thyroid (TR) receptors as agonists or antagonists, altering steroidogenesis, and modifying hormone synthesis, transport, and metabolism.

Chronic exposure to EDCs has been associated with reproductive and developmental abnormalities, thyroid dysfunction, metabolic disorders, and certain hormone-sensitive cancers, as well as adverse effects in aquatic organisms such as feminization of fish populations. Major regulatory frameworks have responded with substance restrictions and data requirements, including EU REACH (Annex XVII entries 51 and 52 and the SVHC candidate list), the EU Biocidal Products Regulation, Regulation (EU) No 10/2011 on plastic food contact materials, Regulation (EC) No 1223/2009 on cosmetics, the RoHS amendment (EU) 2015/863, the US CPSIA, and national standards in China (GB system) and Japan. The OECD Conceptual Framework for Testing and Assessment of Endocrine Disrupters provides a tiered structure that organizes the available in silico, in vitro, and in vivo test methods used to build a weight-of-evidence assessment.

• Receptor-mediated modes of action: estrogenicity, anti-estrogenicity, androgenicity, anti-androgenicity, thyroidal activity
• Non-receptor-mediated modes of action: inhibition of steroidogenesis (aromatase, CYP enzymes), altered hormone metabolism
• Assessment strategy: hazard identification (screening level) followed by hazard characterization (dose-response and adverse outcome confirmation)

Testing Samples

Endocrine disruptor testing is applicable to a broad range of matrices. Sample types are grouped below according to typical regulatory drivers and analytical approaches.

Plastics and Food Contact Materials

Polymeric materials such as PVC compounds, epoxy can coatings, polycarbonate articles, films, gaskets, and closures are tested for bisphenols (BPA, BPS, BPF, BADGE and derivatives) and phthalate plasticizers. Both total content analysis of the material and migration testing into food simulants are performed, depending on whether the article is intended for food contact. Typical requirements come from EU Regulation No 10/2011, the GB 4806 and GB 31604 series, and EN 13130 series methods.

Cosmetics and Personal Care Products

Creams, lotions, shampoos, sunscreens, and color cosmetics are analyzed for parabens, UV filters such as benzophenone derivatives, phthalate contamination from fragrances and packaging, prohibited steroidal hormones, and triclosan, in line with Regulation (EC) No 1223/2009 and corresponding national cosmetic regulations.

Textiles, Leather, and Footwear

Plastisol prints, coated fabrics, synthetic leather, and auxiliaries are tested for phthalates, alkylphenol ethoxylates (nonylphenol and octylphenol ethoxylates used as surfactant residues), organotins, and perfluorinated finishing agents. Common references include GB/T 20388 for phthalates in textiles and restricted substance list (RSL) requirements from global brands.

Toys and Childcare Articles

PVC toys, teethers, bathing articles, and childcare products are subject to strict phthalate limits under EN 71-9/-10/-11, ISO 8124-6, ASTM F963, GB/T 22048, REACH Annex XVII, and the CPSIA. Because these products are prone to mouthing, both content and migration or release-based evaluations may apply.

Electrical and Electronic Products

Plastic housings, cables, connectors, and insulation materials are screened for the four RoHS-regulated phthalates (DEHP, BBP, DBP, DIBP) at the 0.1% limit per (EU) 2015/863, along with brominated flame retardants and short-chain chlorinated paraffins that may also exhibit endocrine activity.

Environmental and Water Samples

Surface water, groundwater, drinking water, wastewater treatment plant effluents, sediment, soil, and biota are analyzed for estrogens, alkylphenols, bisphenols, and total endocrine-disrupting activity. Methods follow standards such as ISO 18857-1 for alkylphenols in water and drinking water quality criteria such as GB 5749.

Testing Items

Testing programs typically combine a targeted list of regulated or restricted EDCs with, where required, effect-based screening of total hormonal activity. The principal analyte groups are listed below.

• Bisphenols and related resins: bisphenol A (BPA), bisphenol S (BPS), bisphenol F (BPF), bisphenol AF (BPAF), bisphenol B (BPB), BADGE, BFDGE, and their hydrolysis and chloride derivatives
• Ortho-phthalates: DEHP, DBP, BBP, DIBP, DINP, DIDP, DNOP, DMP, DEP, DPrP, DHNUP, DCHP, and DMEP
• Alkylphenols and ethoxylates: 4-nonylphenol (NP), 4-tert-octylphenol (OP), nonylphenol ethoxylates (NP1EO to NP9EO), and octylphenol ethoxylates
• Parabens: methyl-, ethyl-, propyl-, butyl-, and benzyl-paraben, together with their common metabolite 4-hydroxybenzoic acid
• Organotin compounds: monobutyltin (MBT), dibutyltin (DBT), tributyltin (TBT), monooctyltin (MOT), dioctyltin (DOT), and triphenyltin (TPhT)
• UV filters and stabilizers: benzophenone-1, benzophenone-2, benzophenone-3 (oxybenzone), 4-methylbenzylidene camphor (4-MBC), and octocrylene
• Antimicrobials: triclosan and triclocarban
• Steroidal hormones: estrone (E1), 17β-estradiol (E2), estriol (E3), 17α-ethinyl estradiol (EE2), testosterone, and progesterone
• Other substances of endocrine concern: perchlorate, selected PFAS, brominated flame retardants, and pesticide residues with known endocrine activity

Results for solid matrices are generally reported in mg/kg or percent by weight; migration results are reported as mg/kg food or mg/dm² against specific migration limits; water samples are reported in ng/L or μg/L. Effect-based results from bioassays are expressed as 17β-estradiol equivalents (EEQ) or analogous equivalence concentrations.

Testing Methods

A robust EDC testing strategy integrates two complementary tiers: targeted chemical analysis, which identifies and quantifies specific substances, and effect-based bioassays, which measure integrated biological activity including contributions from unknown or untargeted compounds.

Chemical Analysis Techniques

• GC-MS and GC-MS/MS: primary technique for phthalates, alkylphenols, and organotins (following derivatization, for example by sodium tetraethylborate ethylation), offering high selectivity in complex polymeric matrices
• LC-MS/MS with electrospray ionization: preferred for thermally labile or polar analytes such as bisphenols, parabens, benzophenones, steroid hormones, and PFAS
• HPLC with UV, diode-array, or fluorescence detection: suitable for high-concentration screening in simpler matrices
• ICP-MS: screening of total tin content as an indicator of organotin presence, followed by speciation analysis
• Sample preparation: ultrasonic-assisted and Soxhlet extraction, accelerated solvent extraction (ASE), and QuEChERS for solids; solid-phase extraction (SPE) enrichment for aqueous samples; migration exposure using food simulants (10% ethanol, 3% acetic acid, 20% and 50% ethanol, and isooctane) under EU 10/2011, EN 13130, and GB 31604 test conditions; solvent extraction per EN 71-10 for toys
• Typical sensitivity: limits of quantification of approximately 0.005 to 0.1 mg/kg for polymeric and consumer product matrices and low ng/L levels for water samples

In Vitro Bioassays

• OECD TG 455: stably transfected human estrogen receptor-α transcriptional activation assay for estrogenic and anti-estrogenic activity
• OECD TG 458: stably transfected human androgen receptor transcriptional activation assay
• OECD TG 493: performance-based receptor binding assay for interaction with the estrogen receptor
• OECD TG 456: H295R steroidogenesis assay measuring effects on estradiol and testosterone production
• Screening-level assays: E-SCREEN cell proliferation assay, yeast estrogenic and androgenic screens (YES/YAS), and thyroid-associated assays such as transthyretin binding and thyroid peroxidase inhibition

In Vivo and Ecotoxicological Assays

• OECD TG 440 uterotrophic assay and OECD TG 441 Hershberger assay for estrogenic/anti-estrogenic and androgenic/anti-androgenic activity in rodents
• OECD TG 407 enhanced 28-day repeated-dose toxicity study with endocrine-sensitive endpoints, and OECD TG 443 extended one-generation reproductive toxicity study (EOGRTS)
• Ecotoxicological assays: OECD TG 229 fish short-term reproduction assay, OECD TG 230 21-day fish assay, OECD TG 234 fish sexual development test, OECD TG 231 amphibian metamorphosis assay, OECD TG 241 larval amphibian growth and development assay, and OECD TG 233 chironomid life-cycle test

Key Standards and Regulatory References

• ISO 8124-6: determination of certain phthalate esters in toys and children's products by GC-MS
• ISO 18857-1: determination of selected alkylphenols and alkylphenol ethoxylates in water
• EN 71-9, EN 71-10, and EN 71-11: organic chemical compounds in toys, including sample solubilization and analytical methods
• GB/T 22048: phthalate plasticizers in toys and children's products; GB/T 20388: phthalates in textiles; GB 31604 series: migration testing of food contact materials; GB 4806 series: food contact safety framework; GB 5749: drinking water quality including DEHP limit values
• ASTM F963: toy safety standard with phthalate restrictions aligned to CPSIA requirements
• REACH Annex XVII entries 51 and 52, the SVHC candidate list, EU RoHS amendment (EU) 2015/863, EU Regulation No 10/2011, and Regulation (EC) No 1223/2009 for substance-specific restrictions and migration limits
• OECD Test Guidelines and OECD Guidance Document No. 150 for the evaluation of endocrine-disrupting properties under a weight-of-evidence framework

Applications

Endocrine disruption testing supports compliance, product stewardship, and research objectives across many industries.

• Regulatory compliance and market access: demonstrating conformity with EU, US, Chinese, Japanese, and international chemical restrictions before product placement
• Product development and material substitution: verifying BPA-free, phthalate-free, or paraben-free claims during reformulation and supplier change management
• Food contact safety: migration assessment of packaging, coatings, and utensils against specific migration limits to protect consumers
• Supply chain control: incoming material inspection, supplier qualification, and periodic surveillance of high-risk components
• Environmental monitoring: surveillance of surface water, effluents, and drinking water for hormonal activity and regulated EDCs, supporting discharge permits and water safety plans
• Chemical registration and risk assessment: generation of endocrine-related endpoints for REACH dossiers, biocide active substance approval, and new chemical notifications under a weight-of-evidence approach consistent with OECD guidance
• Claim substantiation and quality assurance: technical documentation supporting eco-labels, restricted substance lists, and customer-specific requirements

FAQ

What is endocrine disruption testing?

It is the combined use of targeted chemical analysis and biological assays to determine whether a product, material, or sample contains substances capable of interfering with the hormone system, and to quantify those substances against regulatory or client-specific limits.

Which products most commonly require EDC testing?

Toys and childcare articles, plastic and coated food contact materials, cosmetics and personal care products, textiles and footwear with plastic prints or coatings, electronic enclosures and cables, and environmental water samples are the most frequently tested categories.

What is the difference between chemical analysis and bioassays?

Chemical analysis identifies and quantifies known, regulated substances such as BPA or DEHP with high sensitivity and specificity. Bioassays measure the total endocrine activity of a sample, including mixture effects and unidentified contributors, and are therefore valuable complements for screening and for confirming the absence of overall estrogenic or androgenic activity.

What are typical regulatory limits?

Common limits include 0.1% (1000 mg/kg) for regulated phthalates in toys, childcare articles, and electrical products under REACH Annex XVII, RoHS, CPSIA, and ASTM F963; a specific migration limit of 0.05 mg/kg food for BPA in plastic food contact materials under EU Regulation No 10/2011; and low ng/L to μg/L environmental quality thresholds for estrogens and alkylphenols in water.

How much sample is required and how long does testing take?

Chemical analysis generally requires 10 to 50 grams of material or a few finished product units, with turnaround times of five to ten working days. In vitro bioassays may require similar quantities plus extractable volumes, with timelines of two to six weeks. In vivo and ecotoxicological studies require substantially more sample, time, and planning due to their duration and animal welfare review requirements.

Can testing demonstrate that a product is endocrine-safe?

No single test can prove complete absence of endocrine activity. A tiered, weight-of-evidence strategy combining comprehensive targeted screening, effect-based bioassays, and where necessary higher-tier studies provides the strongest technical basis for safety claims and regulatory submissions.

Is the testing performed under recognized quality systems?

Yes. Testing is carried out by accredited third-party laboratories operating under ISO/IEC 17025 quality management systems, using validated methods aligned with OECD, ISO, EN, ASTM, and GB standards wherever available.